Thermo Fisher Scientific Inc.’s TMO recent slew of product launches reflects its ongoing commitment to innovation. The company gains early insights into customer needs through its strong partnerships, ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market ...

Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely ...

Investors focused on top-and-bottom-line performance—important as they are—do so at the risk of neglecting another crucial ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

1 Day TMO -0.01% DJIA -0.32% S&P 500 -0.29% Health Care/Life Sciences -0.52% ...

Sanford C. Bernstein upgraded shares of Thermo Fisher Scientific (NYSE:TMO – Free Report) from a market perform rating to an ...

Thermo Fisher Scientific TMO +0.14% Get Free Report has outperformed the market over the past 15 years by 6.03% on an ...

Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

Brett Girard, chief financial officer and portfolio manager at Liberty International Investment Management, discusses his top ...